Cell Culture & Bioprocessing USA Congress

Over 250 delegates representing leading biotech companies, global pharma organisations and internationally renowned academic institutions

Over 40 presentations, case studies and panel discussions focussing on the key issues in cell line development, 3D cell culture applications, genome editing in cell culture and bioprocessing updates

4 interactive streams:

• Cell Line Development: Early Cell Culture & Cell Line Development
• Process Development: Upstream Bioprocessing and Analytics
• Cell Line Development: Concerns, Applications, Stability, Data & Assay Data Development
• Regenerative Medicine, Cell & Gene Therapy-based Bioprocessing and Manufacturing Strategies

Live Webinars 2019:

Webinar I: Generating Lung Organoids From Human Induced Pluripotent Stem Cells
Hosted by Finn Hawkins, Principal Investigator, Boston University

·         Overview of directed differentiation of induced pluripotent stem cells (iPSCs) to lung epithelium

·         Generating alveolar and airway organoids

·         Disease modelling

Register for Free: https://bit.ly/2NhTWEF 

Webinar II: The Pros & Cons Of Centralized VS Patient Proximal Cell Manufacturing For Autologous Cell Therapy
Hosted by David Peritt, Chief Technology Officer, Sigilon Therapeutics

·         Centralized manufacturing challenges such as cost of goods, supply chain, lot release, time, capital costs, lot failures, etc.

·         Bedside or hospital-based manufacturing challenges such as consistency, lot release, regulatory path, etc.

Register for Free: https://bit.ly/2NjSn9l

Register for Free: https://bit.ly/2NjSn9l